Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Stoltz (NPI 1275584047)

Field	Value
Entity Type	Individual
Organization	Robert Stoltz
Address	114 Cherry St Ne
City	Marietta
State	GA
ZIP	30060
Taxonomy	Specialist
NPI Enumerated	May 15, 2006

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This provider is a retina-focused specialist: the top Medicare revenue drivers are intravitreal pharmacologic therapies (J2777, J0178, J2778) and procedure codes related to in-office injections and retinal imaging such as 67028 and 92134, which matches a clinical model centered on diagnosis and repeat intravitreal treatment rather than broad primary care or surgery. The mix of high-volume anti-VEGF/anti‑VEGF‑class codes and imaging/diagnostic codes indicates an ambulatory retina practice that delivers recurring injection-based care with supporting diagnostic services on site.

Medicare revenue is concentrated in a small number of drug codes: J2777 ($1.1M, 41.0% of this provider's total Medicare revenue), J0178 ($1M, 38.2%), and J2778 ($166.5K, 6.3%) together account for 85.5% of this provider's Medicare revenue. This degree of concentration signals dependency on anti‑VEGF and related intravitreal drug administration as the primary revenue stream.

Payer mix is effectively single‑payer Medicare: lifetime Medicare revenue is $2.6M and there is no Medicaid billing on file, so Medicaid does not contribute to this provider’s billed volume or revenue. For payer- or population-focused contracting, this provider should be treated as a Medicare-centric practice rather than a dual‑payer operation.

Competitive standing on the top drug codes is modest to typical nationally: J2777 is ranked #188 of 2039 providers nationally (91th percentile; typical, unremarkable volume), J0178 is ranked #847 of 3204 (74th percentile; typical, unremarkable volume), and J2778 is ranked #458 of 1208 (62th percentile; typical, unremarkable volume). These ranks indicate the provider is an active but not dominant national participant in administration of these specific drugs.

In contrast, several ancillary and evaluation codes show above‑typical throughput locally: 92134 is ranked #845 of 26868 providers nationally (97th percentile; notably above typical national volume) and 92014 is ranked #2220 of 35415 providers nationally (94th percentile; notably above typical national volume). High relative volume in OCT imaging and comprehensive established exams suggests substantial patient flow for retinal disease management and efficient use of diagnostic capacity.

There are targeted areas of lower relative activity that may reflect case mix or service choice: J7312 (dexamethasone implant) is ranked #462 of 492 providers nationally (5th percentile; typical, unremarkable volume), indicating this provider does not use that implant as a material revenue source compared with peers. Similarly, many general E/M codes (e.g., 99213, 99212) appear at typical or lower national ranks, reinforcing a treatment-focused rather than generalist outpatient practice profile.

Tenure supports an established practice footprint: the provider’s NPI was enumerated on 2006-05-15 (~20 years ago), consistent with a long-standing clinical presence in Marietta, GA. That longevity, combined with the concentrated anti‑VEGF revenue mix and high imaging/exam throughput, suggests an experienced retinal clinic with steady Medicare demand over time.

From a contracting and risk-management perspective, the business-line signal is clear: this practice’s financial performance hinges on intravitreal drug administration and repeat follow-up visits. Any payer engagement, network modeling, or utilization review should prioritize monitoring of J2777 and J0178 utilization patterns (which together represent the vast majority of Medicare revenue) and the high-volume diagnostic services that support that treatment pathway.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	37,200	$30	$1.1M
J0178	Injection, aflibercept, 1 mg	1,460	$690	$1M
J2778	Injection, ranibizumab, 0.1 mg	930	$180	$166.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,460	$100	$144.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	870	$90	$79.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,230	$30	$71.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	170	$120	$20.7K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	120	$150	$17.6K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	230	$70	$15.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	160	$70	$11.5K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Robert Stoltz — 2 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	18	70	970	$680	$700.6K
J2777	7	40	14,100	$30	$524.3K
J2778	16	30	1,170	$180	$286.2K
67028	17	80	720	$90	$71.9K
J7312	12	10	220	$160	$37.6K
92014	44	850	130	$80	$19.7K
99214	13,541	13,640	120	$80	$17.8K
92012	93	380	90	$60	$10.5K
J9035	30	70	120	$50	$10.3K
99213	4,033	13,360	80	$60	$9.2K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Stoltz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stephanie Vanderveldt	GA	Ophthalmology Physician	$4.1M	$0
Sri Krishna Mukkamala	GA	Hospitalist Physician	$3.4M	$0
Alexander Bottini	GA	Retina Specialist (Ophthalmology) Physician	$3M	$0
David Chin Yee	GA	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Gregory Lee	GA	Ophthalmology Physician	$2.9M	$6.3K
Hyung Cho	GA	Ophthalmology Physician	$2.5M	$0
Sean Koh	GA	Ophthalmology Physician	$2.5M	$0
Atul Sharma	GA	Ophthalmology Physician	$2.2M	$0
Mark Rivellese	GA	Ophthalmology Physician	$2.1M	$0
Rahul Komati	IL	Retina Specialist (Ophthalmology) Physician	$1.9M	$0

Nearby Providers

Other providers in the same ZIP code as Robert Stoltz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Quantum Radiology, PC	GA	Diagnostic Radiology Physician	$0	$4.3M
Weijian Zhu	GA	Anatomic Pathology & Clinical Pathology Physician	$2.6M	$4.7K
Marietta Eye Clinic, PA	GA	Ophthalmologic Surgery Clinic/Center	$2.5M	$0
Jeffrey Winter	GA	Vascular Surgery Physician	$2.4M	$0
Annal Meleth	GA	Ophthalmology Physician	$2.2M	$0
Kennestone Hospital, Inc.	GA	General Acute Care Hospital	$0	$1.9M
Lakshmana Kooragayala	GA	Ophthalmology Physician	$1.8M	$0
Kevin Thomas	GA	Dermatopathology (Pathology) Physician	$1.6M	$0
Mark Chastain	GA	Dermatology Physician	$1.6M	$0
Marietta Advanced Surgery Center	GA	Ambulatory Surgical Clinic/Center	$1.3M	$0

Robert Stoltz — Billing Profile & Reimbursement Data

Sign up for Robert Stoltz — Billing Profile & Reimbursement Data policy alerts

Robert Stoltz — Billing Profile & Reimbursement Data

Sign up for Robert Stoltz — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References